Although shortages periodically capture national attention when widely used agents such as cisplatin or carboplatin become scarce, the problem extends well beyond any single drug.
Commentary|Articles|September 4, 2024
- ONCOLOGY Vol 38, Issue 10
- Volume 38
- Issue 10
- Pages: 372-374
Cancer Rehabilitation Medicine: “Bridging the Gap” With Supportive Care
Author(s)Ariana Pelosci
Fact checked by: Russ Conroy
Cancer rehabilitation medicine may help bridge a gap in oncology care, according to Jessica Cheng, MD.
Advertisement
Advertisement
Finding ways to improve quality of life outcomes is always a goal for oncologists. Those in the emerging field of cancer rehabilitation medicine have the opportunity to bridge a gap in oncology care.
Related to this article
Global Burden of Disease data showed alcohol-attributable cancer deaths in the US doubled from 1990 to 2023, with liver cancer showing the steepest rise.
“Far and away, a unified electronic health record is the single use case that could benefit both patients and physicians most, and AI has the potential to help us achieve that,” said Margarita Racsa, MD, MPH.
Nevine Hanna, MD, MPH, FACRO, DABR, detailed how AI auto-contouring and adaptive planning improve efficiency and organ-at-risk sparing in radiation therapy.
How do we implement AI in a way that serves patients? Expert radiation oncologists discuss the crucial question.
Nevine Hanna, MD, MPH, FACRO, DABR, explained how AI can aggregate patient data to enhance multidisciplinary tumor board collaboration.
SOHO 2026 sessions covered chemoimmunotherapy in frontline DLBCL, treatment selection via molecular classifiers, and bispecific antibodies for unfit patients.
The FDA cleared the Triton 1 robotic endoscopy system for diagnostic and therapeutic procedures such as colorectal cancer screening and lesion removal.
Advertisement
Advertisement